Skip to main content
. 2013 Aug 7;33(10):1500–1513. doi: 10.1038/jcbfm.2013.135

Table 1. Potential causes and consequences of proposed BBB dysfunction in AD.

BBB dysfunction Upstream causes Downstream consequences
Disruption Aβ oligomers, truncated tau, inflammation, oxidative stress, diabetes, ApoE4 allele, TBI, vascular disease Leakage of serum components into CNS, neurotoxicity, inflammatory activation
Altered transport Of Aβ ↓LRP-1 Aβ oligomers, inflammation, oxidative stress, diabetes Aβ accumulation in the CNS
    ↓Pgp Aβ oligomers, inflammation, TBI Aβ accumulation in the CNS, altered xenobiotic transport
    ↑RAGE Aβ oligomers, diabetes, inflammation, oxidative stress Aβ accumulation in the CNS, vascular inflammation
  Of glucose ↓GLUT-1 Aβ oligomers, ApoE4 allele Energy deprivation, neuronal dysfunction
Altered secretions Of thrombin Oxidative stress, ischemia   Neurotoxicity, BBB disruption
  Of VEGF Oxidative stress, ischemia   Neurotoxicity, BBB disruption, angiogenesis

Aβ, amyloid-β; AD, Alzheimer's disease; ApoE, Apolipoprotein E; BBB, blood–brain barrier; CNS, central nervous system; LRP-1, lipoprotein receptor-related protein-1; Pgp, P-glycoprotein; RAGE, receptor for advanced glycation endproducts; TBI, traumatic brain injury; VEGF, vascular endothelial growth factor.